Emeritus Professor of Clinical Neurology, Professor Christopher Kennard joins the Medical Sciences Division as its new interim Head of Division today, replacing Professor Alastair Buchan, who will be taking a new role as the University’s Head of Brexit Strategy. For the full story on University of Oxford website
A consortium directed by Dr. Kalyanam Shivkumar at UCLA has received a three-year, $8.6 million grant from the National Institutes of Health (NIH). The consortium hopes to map the heart’s nervous system, ultimately developing new treatments for cardiovascular disease. For the full story on department of physiology, anatomy and genetics website
A study led by Dr Belinda Lennox, a consultant psychiatrist at Oxford Health, has found that specific antibodies (proteins usually produced by the body in response to a foreign threat) are associated with the start of schizophrenia. The study, published in the journal Lancet Psychiatry, is the first to identify this association. Full story on Oxford […]
A major University of Oxford genetics research centre that supports Oxford BRC research is to share £118m of new funding. Full story on NIHR Oxford Biomedical Research Centre website
Oxford University’s Wellcome Trust Centre for Human Genetics (WTCHG) and the leading genome analytics company Genomics plc has announced the first sequencing and analysis of multiple human genomes using nanopore technology. The announcement, made on Thursday, December 1, at the Oxford Nanopore Community Meeting in New York City, marks a major breakthrough in sequencing technology. […]
The IKAlliance, a multinational and multidisciplinary consortium created in response to a Horizon 2020 funding call by the European Commission’s Directorate-General Research and Innovation, has officially started its activities with the kick-off meeting held in Brazil over the 4th and 5th December 2016. Full story on Nuffield Department of Medicine website
The University of Oxford launched its first Public Engagement with Research Strategic Plan to an audience of over 100 staff at a reception at the Pitt Rivers Museum on 12th December 2016. Full story on Medical Sciences Division website
EnzBond, a new biotechnology company from Oxford University, has been formed to commercialise in-silico technology, which makes utilising enzymes in drug manufacturing both cost-effective and time-efficient Full story on Oxford University website
Oxford University, on behalf of Oxford Sciences Innovation (OSI), has announced a substantial increase of capital raised worldwide to scale innovative ideas from the University of Oxford into world-class companies. Full story on Oxford University website
The latest annual report into maternal deaths, produced by Oxford University researchers, highlights the risk of heart disease among pregnant women. Full story on Oxford University website